SG Hiscock & Company commences strategic partnership with abrdn

From

High conviction fund manager SG Hiscock & Company (SG Hiscock) has become the wholesale distribution partner of abrdn in the Australian market, effective yesterday. The firm has also successfully completed the

continue reading

Rate uncertainty, bank collapses adding to sector dispersion

From

Interest rate uncertainty is driving a high level of market volatility and sector returns dispersion as investors grapple with how fast and for how long central banks will raise rates,

continue reading

SG Hiscock appoints Giles Croker as CEO

From

Melbourne-based asset management firm SG Hiscock & Company has appointed Giles Croker as chief executive officer and chief operating officer. Founder and managing director Stephen Hiscock will continue with the

continue reading

Reign of uncertainty creating investment opportunities

From

Australian investors need to focus less on short-term disruptions and place greater emphasis on investments likely to offer long term sustainable earnings growth, according to SG Hiscock & Company portfolio

continue reading

Strong company profits but adaptability remains key

From

Australian companies have enjoyed one of their strongest reporting seasons in recent history helped by pent up demand, closed international borders and a second half of the financial year largely

continue reading

SG Hiscock appoints new investment analyst

From

Melbourne-based boutique fund manager SG Hiscock & Company has appointed Sophie Smith in the role of investment analyst. Ms Smith will join the emerging companies’ business unit, which incorporates the

continue reading

Living with the virus and inflation remain key to navigating markets 

From

Equity markets may be able to continue their rally on the global re-opening dynamic and the vaccine roll-out, but they face a number of issues in the second half of

continue reading

Cultural traits influencing ESG portfolio construction

From

Investment managers are increasingly approaching Environmental, Social and Governance (ESG) factors depending on the cultural nuances or jurisdiction of the investor, according to Morgan Stanley Investment Management lead portfolio specialist,

continue reading

SG Hiscock launches medical technology fund

From

SG Hiscock & Company has launched a new fund that will invest in Australian medical technology companies. The SGH Medical Technology Fund will have a social impact focus and aims

continue reading

Investors wary of emerging investment risks

From

The market continues to shift from the hope to the growth phase as the Australian economy rebounds from the shock of the COVID-19 pandemic and associated lockdowns, but new risks

continue reading